Mohan Venkadesan

From Clinical Insight to Scalable Eye Care Innovation

Mohan Venkadesan builds clinically grounded technologies that transform unmet eye care challenges into scalable solutions for earlier detection, prevention, and better management of vision conditions. From developing the world’s fastest clinically validated colour blindness screening system, delivering results in under six seconds, protected by patent, published in an international peer-reviewed journal, and deployed across international eye care programmes to advancing next generation of diagnostic and preventive technologies, his work bridges research, engineering, human centered design and healthcare delivery to create measurable impact. His innovations have already reached over one million children through eye-screening programmes.

Mohan Venkadesan

Children Screened

Screening Time achieved in clinical assessment

Tertiary Hospital deployments

Clinical Technologies Validated

Patents

Countries

Validated & Deployed Through Eye care Networks

Mohan Venkadesan
Mohan Venkadesan
Mohan Venkadesan
Mohan Venkadesan
Mohan Venkadesan
Mohan Venkadesan
Mohan Venkadesan
Mohan Venkadesan
Mohan Venkadesan
Mohan Venkadesan
Mohan Venkadesan

“My journey began with treating patients and evolved into building independent healthcare technologies. I believe meaningful innovation starts with real clinical problems and succeeds only when it creates measurable impact.”

– Mohan Venkadesan

Currently Building : The Future of Preventive Eye Care

BODVS by Mohan Venkadesan

BioEyes Ophthalmic Digital Vision Screener (BODVS) is the foundation of a broader preventive eye care ecosystem, combining digital screening, intelligent assessment and accessible clinical workflows to enable earlier disease detection and intervention.

A New Approach to Preventive Screening

The platform aims to assist healthcare professionals, screening organizations, and community programs by providing a reliable digital solution for identifying potential vision concerns and supporting timely referral pathways.

Explore Current Build

Mohan’s vision is to contribute to a future where advanced digital technologies make vision screening more accessible, efficient, and impactful worldwide. Through BODVS, he aims to support earlier identification of vision-related concerns and help connect individuals with appropriate eye care services.

Flagship INNOVATIONS

Dalton’s® Pseudo Isochromatic Plates

The world’s fastest clinically validated tool to screen colourblindness in under 6 seconds, developed, patented & trademarked by Mohan Venkadesan, has screened more than ONE MILLION + children across India and Nepal and has been deployed across major Eye care networks. Dalton’s PIP® has also been published in International Research Journal. Available across multiple formats, including Physical, Digital and AI-assisted grading approaches.

Dalton's PIP

AI based Squint Screener

Identifying the level and proximity of squint is a time consuming process today. Mohan developed an AI assisted screening technology designed to support earlier identification of strabismus and improve clinical assessment pathways.

AI Squint Screener by Mohan Venkadesan

Continuous Eye Disease Monitoring Solutions

Prognosis of any disease has to be monitored regularly for credible interventions from the Medics. Mohan has developed an intervention, making continuous eye health monitoring accessible

Cost effective screening solution Mohan

NIIVSU

Portable, Reliable Vision Screening Infrastructure for large-scale programmes

New illuminated vision screener by Mohan Venkadesan

Building at the intersection of clinical expertise, healthcare innovation and scalable technology to create the next generation of preventive eye care systems

Let’s Collaborate 🤝

contact@mohanvenkadesan.com